Illumina drug

Aliases

Illumina Inc., Illumina library preparation protocol

External links

DrugBank · PubChem

No related entities found.

Mentioned in (76)

Papers in which this entity is mentioned.

• Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
• Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. (2025)
• 3D spatial organization of heterogeneous nkx2.5+ progenitors in the zebrafish heart field pre-patterns cardiovascular development. (2025)
• ConsensuSV-ONT - A modern method for accurate structural variant calling. (2025)
• Single cell and spatial alternative splicing analysis with Nanopore long read sequencing. (2025)
• MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
• Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
• SQANTI3: curation of long-read transcriptomes for accurate identification of known and novel isoforms. (2024)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. (2023)
• GenSLMs: Genome-scale language models reveal SARS-CoV-2 evolutionary dynamics. (2022)
• Prenatal alcohol exposure contributes to negative pregnancy outcomes by altering fetal vascular dynamics and the placental transcriptome. (2022)
• Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer. (2022)
• Nanopore sequencing of RNA and cDNA molecules in . (2022)
• Human Retrotransposons and Effective Computational Detection Methods for Next-Generation Sequencing Data. (2022)
• Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing. (2022)
• Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
• Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• Rapid genotype imputation from sequence with reference panels. (2021)
• Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
• Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
• Best practices for variant calling in clinical sequencing. (2020)
• UMI-linked consensus sequencing enables phylogenetic analysis of directed evolution. (2020)
• Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. (2020)
• ASEP: Gene-based detection of allele-specific expression across individuals in a population by RNA sequencing. (2020)
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. (2020)
• Genetic compensation triggered by mutant mRNA degradation. (2019)
• Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. (2019)
• A multi-task convolutional deep neural network for variant calling in single molecule sequencing. (2019)
• HLA*LA-HLA typing from linearly projected graph alignments. (2019)
• Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
• Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants. (2018)
• Unique, dual-indexed sequencing adapters with UMIs effectively eliminate index cross-talk and significantly improve sensitivity of massively parallel sequencing. (2018)
• Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. (2018)
• GeneGini: Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and Diverse Human Transporter Expression Profiles. (2018)
• Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
• Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. (2018)
• Nanopore sequencing and assembly of a human genome with ultra-long reads. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
• Picky comprehensively detects high-resolution structural variants in nanopore long reads. (2018)
• Copy number signatures and mutational processes in ovarian carcinoma. (2018)
• Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017)
• Orthotopic patient-derived xenografts of paediatric solid tumours. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• Mapping and phasing of structural variation in patient genomes using nanopore sequencing. (2017)
• ReMixT: clone-specific genomic structure estimation in cancer. (2017)
• An open access pilot freely sharing cancer genomic data from participants in Texas. (2016)
• Roar: detecting alternative polyadenylation with standard mRNA sequencing libraries. (2016)
• Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells. (2016)
• Integrative clinical genomics of advanced prostate cancer. (2015)
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. (2015)
• ENVE: a novel computational framework characterizes copy-number mutational landscapes in colorectal cancers from African American patients. (2015)
• Spatial reconstruction of single-cell gene expression data. (2015)
• Robust enumeration of cell subsets from tissue expression profiles. (2015)
• Comprehensive genomic profiles of small cell lung cancer. (2015)
• Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. (2014)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
• The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. (2014)
• HLA typing from 1000 genomes whole genome and whole exome illumina data. (2013)
• A comparative analysis of algorithms for somatic SNV detection in cancer. (2013)
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. (2013)
• Characterizing and measuring bias in sequence data. (2013)
• High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. (2012)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
• DELLY: structural variant discovery by integrated paired-end and split-read analysis. (2012)
• Summarizing and correcting the GC content bias in high-throughput sequencing. (2012)
• Integrative analysis of the melanoma transcriptome. (2010)
• TumorBoost: normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. (2010)
• Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. (2010)
• Fast and accurate short read alignment with Burrows-Wheeler transform. (2009)
• RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. (2008)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.